← Leaderboards
Morie A Gertz
Mayo Clinic
$1,423,624
Attributed
$1,423,624
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.9K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,423,624 · 1
By mechanism
R01$1,423,624 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Gene Rearrangement”
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$27,554,408
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- Frederick W Alt · Boston Children'S Hospital$21,195,030
- Gerard David Schellenberg · University Of California San Diego$20,486,450
- Jianjun Chen · Beckman Research Institute/City Of Hope$20,258,992
Research focus
Gene RearrangementFrequencies (Time Pattern)DoseExperimental GeneticsEnrollmentAftercareBase SequenceAmyloidDisease ProgressionB-LymphocytesAutologous Stem Cell TransplantationCatabolismCell LineageCessation Of LifeChemotherapyCircular DichroismAmyloid FormationClinical TrialsClinical Trials DesignAmyloidosisCloningDepositionBone MarrowGenes
Grant awards (6)
Phase 3 stem cell transplant for light chain amyloidosis$163,055
R01 · FY2011 · CA · contact PI
Phase 3 stem cell transplant for light chain amyloidosis$267,768
R01 · FY2010 · CA · contact PI
Phase 3 stem cell transplant for light chain amyloidosis$301,913
R01 · FY2009 · CA · contact PI
Phase 3 stem cell transplant for light chain amyloidosis$348,948
R01 · FY2008 · CA · contact PI
Phase 3 stem cell transplant for light chain amyloidosis$89,942
R01 · FY2007 · CA · contact PI
Phase 3 stem cell transplant for light chain amyloidosis$251,998
R01 · FY2005 · CA